Authors: Runnebaum, IB Wang-Gohrke, S Vesprini, D Kreienberg, R Lynch, H Moslehi, R Ghadirian, P Weber, B Godwin, AK Risch, H Garber, J Lerman, C Olopade, OI Foulkes, WD Karlan, B Warner, E Rosen, B Rebbeck, T Tonin, P Dube, MP Kieback, DG Narod, SA

Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638

Authors: Shin, HR Kim, JY Ohno, T Cao, K Mizokami, M Risch, H Kim, SK

Citation: Hr. Shin et al., Prevalence and risk factors of hepatitis C virus infection among Koreans in rural area of Korea, HEPATOL RES, 17(3), 2000, pp. 185-196

Authors: Moslehi, R Chu, W Karlan, B Fishman, D Risch, H Fields, A Smotkin, D Ben-David, Y Rosenblatt, J Russo, D Schwartz, P Tung, N Warner, E Rosen, B Friedman, J Brunet, JS Narod, SA

Citation: R. Moslehi et al., BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer, AM J HU GEN, 66(4), 2000, pp. 1259-1272

Authors: Zweemer, RP Shaw, PA Verheijen, RMH Ryan, A Berchuck, A Ponder, BAJ Risch, H McLaughlin, JR Narod, SA Menko, FH Kenemans, P Jacobs, IJ

Citation: Rp. Zweemer et al., Accumulation of p53 protein is frequent in ovarian cancers associated withBRCA1 and BRCA2 germline mutations, J CLIN PATH, 52(5), 1999, pp. 372-375

Authors: Wang-Gohrke, S Weikel, W Risch, H Vesprini, D Abrahamson, J Lerman, C Godwin, A Moslehi, R Olipade, O Brunet, JS Stickeler, E Kieback, DG Kreienberg, R Weber, B Narod, SA Runnebaum, IB

Citation: S. Wang-gohrke et al., Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations, BR J CANC, 81(1), 1999, pp. 179-183